Through stepwise rational design of TCR–pMHC affinity (63, 64), we created a unique panel of human CD8 TCRs specific for the cancer testis antigen NY-ESO-1157–165 presented by HLA-A*0201 (defined as A2 thereafter) (66). This evidence concerns the gene CD8A and cancer.